EMEA-001238-PIP02-20 - paediatric investigation plan

vatiquinone

Key facts

• Active substance:
  vatiquinone
• Therapeutic area:
  Neurology
• Decision number:
  P/0318/2021
• PIP number:
  EMEA-001238-PIP02-20
• Pharmaceutical form(s):
  Oral solution
• Condition(s) / indication(s):
  Treatment of mitochondrial disease
• Route(s) of administration:
  Oral use
• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  11/08/2021
• Compliance check done:
  No

Decision

P/0318/2021 : EMA decision of 11 August 2021 on the agreement of a paediatric investigation plan for vatiquinone (EMEA-001238-PIP02-20)

Adopted Reference Number: EMA/427603/2021